A61K 38/48
Acting on peptide bonds
Official title: acting on peptide bonds (3.4)
A61K38/48 (Acting on peptide bonds) appears on 3,457 US grants and 6,070 published applications in this corpus.
Search patents in A61K- Granted patents
- 3,457
- Published applications
- 6,070
- Assignees
- 1,971
- Inventors
- 7,468
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 4 | 0 |
| 1978 | 1 | 0 |
| 1979 | 5 | 0 |
| 1980 | 0 | 0 |
| 1981 | 5 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 14 | 0 |
| 1985 | 8 | 0 |
| 1986 | 6 | 0 |
| 1987 | 8 | 0 |
| 1988 | 6 | 0 |
| 1989 | 13 | 0 |
| 1990 | 15 | 0 |
| 1991 | 22 | 0 |
| 1992 | 20 | 0 |
| 1993 | 16 | 0 |
| 1994 | 20 | 0 |
| 1995 | 21 | 0 |
| 1996 | 29 | 0 |
| 1997 | 28 | 0 |
| 1998 | 50 | 0 |
| 1999 | 49 | 0 |
| 2000 | 53 | 0 |
| 2001 | 52 | 32 |
| 2002 | 75 | 132 |
| 2003 | 57 | 169 |
| 2004 | 42 | 197 |
| 2005 | 66 | 198 |
| 2006 | 65 | 200 |
| 2007 | 65 | 199 |
| 2008 | 77 | 236 |
| 2009 | 54 | 197 |
| 2010 | 92 | 261 |
| 2011 | 99 | 252 |
| 2012 | 126 | 241 |
| 2013 | 159 | 255 |
| 2014 | 180 | 322 |
| 2015 | 199 | 286 |
| 2016 | 177 | 319 |
| 2017 | 190 | 279 |
| 2018 | 189 | 267 |
| 2019 | 185 | 340 |
| 2020 | 175 | 268 |
| 2021 | 175 | 280 |
| 2022 | 136 | 256 |
| 2023 | 117 | 273 |
| 2024 | 130 | 253 |
| 2025 | 108 | 201 |
| 2026 | 68 | 157 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Protease composition6 Oct 2026US 12,751,997 B2Anatara Lifesciences Limited
- Methods of treating ischemic disease by administering an ATR kinase inhibitor22 Sep 2026US 12,740,980 B2East Tennessee State University Research Foundation
- Method and medicine for treating Huntington's disease15 Sep 2026US 12,734,222 B2Talengen International Limited
- Bromelain protease, bromelain, jacalin-like lectin, extract from the stem and/or the fruit of a pineapple plant, combination preparation, bromelain protease inhibitor, protein/protease mix, and glycated bromelain protein formed by exogenous non-enzymatic glycation, for use in the treatment or prophylaxis of virus infections caused by coronaviruses in a human or animal15 Sep 2026US 12,734,223 B2Helmholtz-Institut FüR Pharmazeutische Forschung Saarland
- Compositions comprising a tweak ligand and methods of using same25 Aug 2026US 12,714,740 B2Children's Hospital Medical Center
- Composition for inducing immunotolerance8 Oct 2026US 2026/0306540 A1
- Plasmin-induced internal limiting membrane digestion facilitates donor retinal ganglion cell transplantation8 Oct 2026US 2026/0306549 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Human factor vii deletion constructs for treating cancer8 Oct 2026US 2026/0306592 A1The Cleveland Clinic Foundation
- Stabilized liquid and lyophilized adamts13 formulations8 Oct 2026US 2026/0306593 A1Takeda Pharmaceutical Company Limited
- Lifting agent with therapeutics8 Oct 2026US 2026/0306594 A1Boston Scientific Scimed, Inc.
Most cited
By later US patents
- Non-immunogenic polypeptides2,007US 4,179,337 A1979
- Drug delivery system making use of a hydrogel polymer coating1,007US 5,304,121 ABoston Scientific Corporation · 1994
- Biodegradable botulinum toxin implant657US 6,506,399 B2Allergan Sales, Inc. · 2003
- Supplemented and unsupplemented tissue sealants, methods of their production and use441US 6,197,325 B1American National Red Cross · 2001
- Drug delivery390US 5,674,192 ABoston Scientific Corporation · 1997